Pricing Log in Create free account

Autolus Therapeutics PLC Sponsored ADR (AUTL) vs Eupraxia Pharmaceuticals Inc. (EPRX)

Autolus Therapeutics PLC Sponsored ADR and Eupraxia Pharmaceuticals Inc. are both Biotechnology companies. Autolus Therapeutics PLC Sponsored ADR and Eupraxia Pharmaceuticals Inc. are of similar size ($457.8M and $446.2M). Eupraxia Pharmaceuticals Inc. has the higher net margin (0.00% vs −238.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Eupraxia Pharmaceuticals Inc. leads on 9 and Autolus Therapeutics PLC Sponsored ADR on 3.

Valuation

Metric AUTL EPRX Biotechnology median
P/E n/m n/m 8.50
P/S 3.63 n/m 9.71
P/B 5.69 4.38 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 2.56 n/m 9.21
Earnings yield (66.25%) (15.41%) (33.15%)
Free cash flow yield (59.62%) (8.72%) (25.50%)

Profitability

Metric AUTL EPRX Biotechnology median
Gross margin 15.66% — 65.16%
Operating margin (210.78%) 0.00% 0.00%
Net margin (238.66%) 0.00% 0.00%
Free cash flow margin (198.26%) 0.00% 0.00%
Return on equity (133.00%) (117.82%) (56.36%)
Return on assets (46.15%) (64.44%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric AUTL EPRX Biotechnology median
Revenue growth (TTM) 193.29% — 6.02%
EPS growth (last fiscal year) (25.58%) (35.53%) 30.26%
Revenue growth, 5-year CAGR 113.11% — 9.41%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric AUTL EPRX Biotechnology median
Debt to equity 1.04 0.01 0.00
Current ratio 4.89 16.00 4.72
Net debt to EBITDA 1.16 2.11 0.96

Dividend

Metric AUTL EPRX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric AUTL EPRX Biotechnology median
Market cap 457.80m 446.21m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack